Dominik Schneidawind

Publications

• Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia. Schneidawind D, Federmann B, Faul C, Vogel W, Kanz L, Bethge WA. Ann Hematol. 2013
• Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis. Schneidawind D, Nann D, Vogel W, Faul C, Fend F, Horger M, Kanz L, Bethge W. Transpl Infect Dis. 2012; 14 (6): E166-72
• [Allogeneic stem cell transplantation for acute myeloid leukemia and HIV infection--case 3/2012]. Schneidawind D, Dorn C, Faul C, Vogel W, Berg C, Beck R, Korn K, Dittmann H, Schleicher J, Erbersdobler A, Jahn G, Kanz L, Bethge W. Dtsch Med Wochenschr. 2012; 137 (10): 495
• Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant. Schneidawind D, Schmitt A, Wiesneth M, Mertens T, Bunjes D, Freund M, Schmitt M. Leuk Lymphoma. 2010; 51 (6): 1055-62